KM Financial Solutions | UPDATE 3-U.S. judge in Texas invalidates Allergan patents on Restasis
1794
post-template-default,single,single-post,postid-1794,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 3-U.S. judge in Texas invalidates Allergan patents on Restasis

UPDATE 3-U.S. judge in Texas invalidates Allergan patents on Restasis

Oct 16 (Reuters) – A U.S. judge on Monday invalidated
patents on Allergan Plc’s dry-eye medicine Restasis on
grounds that the patents cover ideas that are obvious, sending
shares of the pharmaceutical company down 3.5 percent.

No Comments

Post A Comment